Angela T. Mchugh
Dundee, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
The Identification of Potential Therapeutic Targets for Cutaneous Squamous Cell Carcinoma.
Journal: The Journal of investigative dermatology
Published: October 05, 2018
Targeting the spliceosome for cutaneous squamous cell carcinoma therapy: a role for c-MYC and wild-type p53 in determining the degree of tumour selectivity.
Journal: Oncotarget
Published: December 09, 2017
Preclinical comparison of proteasome and ubiquitin E1 enzyme inhibitors in cutaneous squamous cell carcinoma: the identification of mechanisms of differential sensitivity.
Journal: Oncotarget
Published: September 29, 2017
CREBBP mutation in human cutaneous squamous cell carcinoma.
Journal: Experimental dermatology
Published: April 05, 2016
Inactivation of TGFβ receptors in stem cells drives cutaneous squamous cell carcinoma.
Journal: Nature communications
Published: February 25, 2016
Novel CARD11 Mutations in Human Cutaneous Squamous Cell Carcinoma Lead to Aberrant NF-κB Regulation.
Novel CARD11 Mutations in Human Cutaneous Squamous Cell Carcinoma Lead to Aberrant NF-κB Regulation.
Journal: The American journal of pathology
Published: December 18, 2014
NOTCH1 mutations occur early during cutaneous squamous cell carcinogenesis.
Journal: The Journal of investigative dermatology
Published: January 27, 2014
Methylated tissue factor pathway inhibitor 2 (TFPI2) DNA in serum is a biomarker of metastatic melanoma.
Journal: The Journal of investigative dermatology
Published: February 15, 2013
NT5E CpG island methylation is a favourable breast cancer biomarker.
Journal: British journal of cancer
Published: June 02, 2012
NT5E (CD73) is epigenetically regulated in malignant melanoma and associated with metastatic site specificity.
Journal: British journal of cancer
Published: March 29, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026